Nj State Employees Deferred Compensation Plan Wave Life Sciences Ltd. Transaction History
Nj State Employees Deferred Compensation Plan
- $800 Million
- Q4 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 11,700 shares of WVE stock, worth $142,623. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,700
Previous 11,700
-0.0%
Holding current value
$142,623
Previous $95,000
51.58%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding WVE
# of Institutions
168Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$222 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$122 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$118 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$82.1 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$75.1 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.06B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...